NANO DISCOVERY, INC.

nanodiscoveryinc.com

Nano Discovery Inc. is a biotechnology company based in Orlando, Florida, United States. Nano Discovery developed, manufactures and sells single-step and washing-free immunoassay technology, D2Dx™. D2Dx™ is a platform technology that can be used for the detection and analysis of both antibody and antigen proteins. Using the conjugation kits and assay reader from Nano Discovery, any immunoassay can be customized to specific needs within hours. D2Dx™ immunoassay is simple to use with assay results obtained within 5-30 minutes. Nano Discovery’s unique technology and methodology were developed by Dr. Qun (Treen) Huo at the University of Central Florida’s Department of Chemistry and NanoScience Technology Center. Huo used a variety of UCF’s Tech Transfer programs in creating Nano Discovery Inc. at the UCF Business Incubator. The company is led by biotechnology entrepreneur and investor Davian Santana. For more information visit www.nanodiscoveryinc.com and follow us on Twitter @nanodiscovery.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

ORANGEWOOD PARTNERS MAKES STRATEGIC INVESTMENT IN BARRINGTON JAMES

Orangewood and Barrington James | October 06, 2022

news image

Orangewood Partners a long-term focused private investment firm, announced an investment in Barrington James, a leading global recruitment firm that primarily serves the pharmaceutical, biotechnology and medical device sectors. Terms of the transaction were not disclosed. In partnering with Orangewood, Barrington James intends to enhance its global recruiting solutions, expand its client-service capabilities and support its ongoing commitment to developing and utilizing cutting-ed...

Read More

MedTech

PANGIA BIOTECH PLANS EXPANDED MULTI-CANCER EARLY DETECTION LIQUID BIOPSY STUDY

PanGIA Biotech, Inc. | January 05, 2024

news image

PanGIA Biotech, a US based biotechnology company with a mission to develop true liquid biopsy technology that is scalable for global impact, today announced that it is finalizing its three-year, prospective, multicenter, clinical study on prostate cancer liquid biopsy. This announcement comes as the company prepares to launch additional clinical studies in multi-cancer early detection using the PanGIA® Liquid Biopsy Platform. “The PanGIA urine based true liquid biopsy technology ...

Read More

ROIVANT PROVIDES UPDATES FOR PIVOTAL BREATHE CLINICAL TRIAL EVALUATING GIMSILUMAB IN COVID-19

Roivant | May 13, 2020

news image

Roivant Sciences today announced several updates for its adaptive, randomized, double-blind, placebo-controlled, multi-center pivotal BREATHE trial evaluating the impact of intravenous (IV) treatment with gimsilumab on mortality in COVID-19 patients with lung injury or ARDS.The independent Data Monitoring Committee (DMC) for BREATHE unanimously recommended that the trial continue after a pre-specified safety assessment evaluating data from the first 10% of randomized subjects after six day...

Read More

MedTech

STEVANATO GROUP LAUNCHES EZ-FILL® KIT AND LABORATORY FILL AND FINISH SERVICE TO SUPPORT SMALL BATCH DRUG DEVELOPMENT AND COMMERCIALIZATION

Stevanato Group | January 25, 2024

news image

Stevanato Group S.p.A. a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, unveiled today two new offerings for efficient small batch pharmaceutical manufacturing: the EZ-fill® Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers (TEC). In a context where reducing time-to-market is key, Stevanato Group’s new EZ-fill® Kit offers fast access to ...

Read More
news image

Cell and Gene Therapy

ORANGEWOOD PARTNERS MAKES STRATEGIC INVESTMENT IN BARRINGTON JAMES

Orangewood and Barrington James | October 06, 2022

Orangewood Partners a long-term focused private investment firm, announced an investment in Barrington James, a leading global recruitment firm that primarily serves the pharmaceutical, biotechnology and medical device sectors. Terms of the transaction were not disclosed. In partnering with Orangewood, Barrington James intends to enhance its global recruiting solutions, expand its client-service capabilities and support its ongoing commitment to developing and utilizing cutting-ed...

Read More
news image

MedTech

PANGIA BIOTECH PLANS EXPANDED MULTI-CANCER EARLY DETECTION LIQUID BIOPSY STUDY

PanGIA Biotech, Inc. | January 05, 2024

PanGIA Biotech, a US based biotechnology company with a mission to develop true liquid biopsy technology that is scalable for global impact, today announced that it is finalizing its three-year, prospective, multicenter, clinical study on prostate cancer liquid biopsy. This announcement comes as the company prepares to launch additional clinical studies in multi-cancer early detection using the PanGIA® Liquid Biopsy Platform. “The PanGIA urine based true liquid biopsy technology ...

Read More
news image

ROIVANT PROVIDES UPDATES FOR PIVOTAL BREATHE CLINICAL TRIAL EVALUATING GIMSILUMAB IN COVID-19

Roivant | May 13, 2020

Roivant Sciences today announced several updates for its adaptive, randomized, double-blind, placebo-controlled, multi-center pivotal BREATHE trial evaluating the impact of intravenous (IV) treatment with gimsilumab on mortality in COVID-19 patients with lung injury or ARDS.The independent Data Monitoring Committee (DMC) for BREATHE unanimously recommended that the trial continue after a pre-specified safety assessment evaluating data from the first 10% of randomized subjects after six day...

Read More
news image

MedTech

STEVANATO GROUP LAUNCHES EZ-FILL® KIT AND LABORATORY FILL AND FINISH SERVICE TO SUPPORT SMALL BATCH DRUG DEVELOPMENT AND COMMERCIALIZATION

Stevanato Group | January 25, 2024

Stevanato Group S.p.A. a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, unveiled today two new offerings for efficient small batch pharmaceutical manufacturing: the EZ-fill® Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers (TEC). In a context where reducing time-to-market is key, Stevanato Group’s new EZ-fill® Kit offers fast access to ...

Read More